Intercellular communication in Epstein Barr virus reactivation
Epstein Barr 病毒重新激活中的细胞间通讯
基本信息
- 批准号:9035348
- 负责人:
- 金额:$ 37.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-10 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS-Related Non-Hodgkin&aposs LymphomaAutomobile DrivingB-LymphocytesCell CommunicationCellsComplexCuesEnvironmentEpithelialEpithelial CellsEpitheliumEpstein-Barr Virus InfectionsEpstein-Barr Virus latencyEventFamilyFractionationGenesHuman Herpesvirus 4InvestigationLymphocyteLytic PhaseMediatingMembraneMicroscopyModelingOralPathway interactionsPhenotypePoriferaProteomicsReactionReceptors, Antigen, B-CellRegulatory PathwayRoleSalivaSeriesStagingStructure of germinal center of lymph nodeTonsilTransforming Growth Factor betaTransforming Growth Factor beta ReceptorsVesicleViralViral reservoirVirusWorkcomparative efficacyin vivoinfected B cellintercellular communicationlive cell imagingoral cavity epitheliumprogramsresponseretroviral transductiontissue culturetraffickingtranscriptome sequencingtransmission processtumor
项目摘要
DESCRIPTION (provided by applicant): The Epstein-Barr virus (EBV) is highly penetrant in AIDS-associated non-Hodgkin's lymphomas where it is a key driver of the tumor phenotype. While EBV latency genes are critical for facilitating the tumor phenotype, the switch from latency to the lytic cycle is a critical aspect of a successful EBV infection program. As a result, the mechanisms driving this switch have been topics of active investigation over the years. Although EBV reactivation can be achieved in tissue culture through stimulation of the B-cell receptor (with anti-Ig) or the TGF-beta receptor (with ectopic TGF-beta), it is uncertain how common such events are in EBV-infected lymphocytes in vivo (work from David Thorley-Lawson's lab). The overarching hypothesis of this application is that EBV has evolved with a sensing mechanism for latently infected B-cells to detect when they encounter an epithelial cell environment. This model proposes that environmental cues from the oral/tonsil epithelium (in the late stages of the germinal center reaction, for example) trigger reactivation in B-cells, thereby facilitating the B-cell to epithelial cell viral transfer that is a fundamental first step n oral epithelial plaque formation and host- to-host transmission.
描述(申请人提供):爱泼斯坦-巴尔病毒(EBV)在艾滋病相关的非霍奇金淋巴瘤中具有高度渗透性,它是肿瘤表型的关键驱动因素。虽然EBV潜伏期基因对促进肿瘤表型至关重要,但从潜伏期到裂解周期的转换是成功的EBV感染计划的关键方面。因此,推动这种转变的机制多年来一直是积极研究的主题。虽然在组织培养中可以通过刺激B细胞受体(带有抗-Ig)或转化生长因子-β受体(具有异位转化生长因子-β)来实现EBV的重新激活,但目前还不确定在体内EBV感染的淋巴细胞中此类事件有多常见(David Thorley-Lawson实验室的工作)。这项应用的主要假设是,EBV已经进化出一种感知机制,可以让潜伏感染的B细胞在遇到上皮细胞环境时检测到它们。该模型认为,来自口腔/扁桃体上皮的环境信号(例如,在生发中心反应的后期)会触发B细胞的重新激活,从而促进B细胞到上皮细胞的病毒转移,这是口腔上皮细胞斑块形成和宿主到宿主传播的基本第一步。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.
- DOI:10.1186/1743-422x-10-152
- 发表时间:2013-05-16
- 期刊:
- 影响因子:4.8
- 作者:Sides MD;Sosulski ML;Luo F;Lin Z;Flemington EK;Lasky JA
- 通讯作者:Lasky JA
Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas.
- DOI:10.1038/srep24927
- 发表时间:2016-04-25
- 期刊:
- 影响因子:4.6
- 作者:Zhang W;Edwards A;Fang Z;Flemington EK;Zhang K
- 通讯作者:Zhang K
The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
- DOI:10.1016/j.compbiolchem.2016.02.005
- 发表时间:2016-08
- 期刊:
- 影响因子:3.1
- 作者:Zhang W;Edwards A;Fan W;Flemington EK;Zhang K
- 通讯作者:Zhang K
Somatic mutations favorable to patient survival are predominant in ovarian carcinomas.
- DOI:10.1371/journal.pone.0112561
- 发表时间:2014
- 期刊:
- 影响因子:3.7
- 作者:Zhang W;Edwards A;Flemington E;Zhang K
- 通讯作者:Zhang K
Inferring polymorphism-induced regulatory gene networks active in human lymphocyte cell lines by weighted linear mixed model analysis of multiple RNA-Seq datasets.
- DOI:10.1371/journal.pone.0078868
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Zhang W;Edwards A;Flemington EK;Zhang K
- 通讯作者:Zhang K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIK K FLEMINGTON其他文献
ERIK K FLEMINGTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIK K FLEMINGTON', 18)}}的其他基金
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
EBV 重新激活导致广泛的宿主从头启动子转录和转录干扰
- 批准号:
10647826 - 财政年份:2022
- 资助金额:
$ 37.63万 - 项目类别:
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
EBV 重新激活导致广泛的宿主从头启动子转录和转录干扰
- 批准号:
10548370 - 财政年份:2022
- 资助金额:
$ 37.63万 - 项目类别:
Programmed splicing derangement as new EBV host cell shut-off mechanism
程序性剪接紊乱作为新的 EBV 宿主细胞关闭机制
- 批准号:
10580068 - 财政年份:2022
- 资助金额:
$ 37.63万 - 项目类别:
Programmed splicing derangement as new EBV host cell shut-off mechanism
程序性剪接紊乱作为新的 EBV 宿主细胞关闭机制
- 批准号:
10446536 - 财政年份:2022
- 资助金额:
$ 37.63万 - 项目类别:
RPMS1 circular RNAs in EBV malignancies
EBV 恶性肿瘤中的 RPMS1 环状 RNA
- 批准号:
10397562 - 财政年份:2019
- 资助金额:
$ 37.63万 - 项目类别:
RPMS1 circular RNAs in EBV malignancies
EBV 恶性肿瘤中的 RPMS1 环状 RNA
- 批准号:
10612751 - 财政年份:2019
- 资助金额:
$ 37.63万 - 项目类别:
RPMS1 circular RNAs in EBV malignancies
EBV 恶性肿瘤中的 RPMS1 环状 RNA
- 批准号:
10153734 - 财政年份:2019
- 资助金额:
$ 37.63万 - 项目类别:
Project 2: Joint Transcriptomic and Epigenomic Studies for Male Osteoporosis
项目2:男性骨质疏松症的转录组和表观基因组联合研究
- 批准号:
10180819 - 财政年份:2017
- 资助金额:
$ 37.63万 - 项目类别:
"Core B" Viral RNA-seq and bioinformatics Core
“核心 B”病毒 RNA-seq 和生物信息学核心
- 批准号:
10403019 - 财政年份:2017
- 资助金额:
$ 37.63万 - 项目类别:
"Core B" Viral RNA-seq and bioinformatics Core
“核心 B”病毒 RNA-seq 和生物信息学核心
- 批准号:
10646252 - 财政年份:2017
- 资助金额:
$ 37.63万 - 项目类别:
相似海外基金
Establishment of a novel genomic approach to non-invasive therapeutic response assessment & monitoring of minimal residual disease (MRD) in patients with Non-Hodgkin´s Lymphoma
建立一种新的基因组方法来评估非侵入性治疗反应
- 批准号:
249636657 - 财政年份:2013
- 资助金额:
$ 37.63万 - 项目类别:
Research Fellowships
The interaction of Burkitt???s lymphoma cofactors EBV and Plasmodium
伯基特淋巴瘤辅助因子 EBV 和疟原虫的相互作用
- 批准号:
8574478 - 财政年份:2012
- 资助金额:
$ 37.63万 - 项目类别:
Functional characterization of Gonadotropin Releasing Hormone Receptor (GnRH-R) in Non Hodgkin´s Lymphoma (NHL) and Urothelial Carcinoma- a novel therapeutic target
促性腺激素释放激素受体 (GnRH-R) 在非霍奇金淋巴瘤 (NHL) 和尿路上皮癌中的功能特征 - 一种新的治疗靶点
- 批准号:
229001970 - 财政年份:2012
- 资助金额:
$ 37.63万 - 项目类别:
Research Grants
HT and Risk of Non-Hodgkin;s Lymphoma (NHL)
HT 和非霍奇金淋巴瘤 (NHL) 的风险
- 批准号:
6999265 - 财政年份:2005
- 资助金额:
$ 37.63万 - 项目类别:
HT and Risk of Non-Hodgkin;s Lymphoma (NHL)
HT 和非霍奇金淋巴瘤 (NHL) 的风险
- 批准号:
7310805 - 财政年份:
- 资助金额:
$ 37.63万 - 项目类别:
HT and Risk of Non-Hodgkin;s Lymphoma (NHL)
HT 和非霍奇金淋巴瘤 (NHL) 的风险
- 批准号:
7492977 - 财政年份:
- 资助金额:
$ 37.63万 - 项目类别:
HT and Risk of Non-Hodgkin;s Lymphoma (NHL)
HT 和非霍奇金淋巴瘤 (NHL) 的风险
- 批准号:
7661556 - 财政年份:
- 资助金额:
$ 37.63万 - 项目类别: